Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.
Open | $30.46 |
Close | $30.16 |
Volume / Avg. | 213.01K / 539.66K |
Day Range | 30.03 - 31.21 |
52 Wk Range | 9.60 - 45.31 |
Market Cap | $1.85B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 18.58% |
Days to Cover | 21.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.
Other companies in Kymera Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Apogee Therapeutics (NASDAQ:APGE), Novavax (NASDAQ:NVAX) and CG Oncology (NASDAQ:CGON).
There is no analysis for Kymera Therapeutics.
Kymera Therapeutics has a consensus price target of $42.00.
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $30.19 last updated July 3, 2024 at 3:29 PM EDT.
There are no upcoming dividends for Kymera Therapeutics.
Kymera Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Kymera Therapeutics.
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.